Large Scale Production and Downstream Processing of Labyrinthopeptins from the Actinobacterium .

Rupcic, Zeljka; Hüttel, Stephan; Bernecker, Steffen; Kanaki, Sae; Stadler, Marc

dc.contributor.author	Rupcic, Zeljka
dc.contributor.author	Hüttel, Stephan
dc.contributor.author	Bernecker, Steffen
dc.contributor.author	Kanaki, Sae
dc.contributor.author	Stadler, Marc
dc.date.accessioned	2018-06-29T14:34:33Z
dc.date.available	2018-06-29T14:34:33Z
dc.date.issued	2018-06-05
dc.identifier.issn	2306-5354
dc.identifier.pmid	29874859
dc.identifier.doi	10.3390/bioengineering5020042
dc.identifier.uri	http://hdl.handle.net/10033/621418
dc.description.abstract	A method was established for the production of 1.2-fold and 4.2-fold increased amounts of the antiviral and central nervous system-active lantipeptides, labyrinthopeptins A1 and A2, respectively, isolated from the actinobacterium	en_US
dc.rights	Attribution-NonCommercial-ShareAlike 3.0 United States	*
dc.rights.uri	http://creativecommons.org/licenses/by-nc-sa/3.0/us/	*
dc.subject	anti-viral agents	en_US
dc.subject	bioprocess	en_US
dc.subject	central nervous system	en_US
dc.subject	lantibiotics	en_US
dc.subject	optimization production	en_US
dc.subject	reversed phase-high performance liquid chromatography	en_US
dc.subject	scale-up	en_US
dc.title	Large Scale Production and Downstream Processing of Labyrinthopeptins from the Actinobacterium .	en_US
dc.type	Article	en_US
dc.contributor.department	Helmholtz-Zentrum für Infektionsforschung GmbH, Inhoffenstr. 7, 38124 Braunschweig, Germany.	en_US
refterms.dateFOA	2018-06-29T14:34:34Z
dc.source.journaltitle	Bioengineering (Basel, Switzerland)